Market Overview

UPDATE: Sterne Agee Initiates Coverage on AmerisourceBergen on Dominant Market Share

Share:
Related ABC
Benzinga's Top Downgrades
Cowen & Company Downgrades AmerisourceBergen To Market Perform
Cardinal Health's $1.94B Buyout Offer Accepted by Cordis - Analyst Blog (Zacks)

In a report published Thursday, Sterne Agee analyst Greg T. Bolan initiated coverage on AmerisourceBergen Corp. (NYSE: ABC) with a Buy rating and $80.00 price target.

In the report, Sterne Agee noted, “With specialty drugs expected to capture an increasingly large footprint within the drug spend funnel, we believe ABC's dominant share within the specialty distribution channel will enable the company to achieve revenue growth and margins superior to those of its peers. Initiate with a Buy rating and $80 price target.”

AmerisourceBergen Corp. closed on Wednesday at $61.49.

Latest Ratings for ABC

DateFirmActionFromTo
May 2015Cowen & CompanyDowngradesOutperformMarket Perform
May 2015Argus ResearchMaintainsBuy
May 2015BarclaysMaintainsEqual-weight

View More Analyst Ratings for ABC
View the Latest Analyst Ratings

Posted-In: Greg T. Bolan Sterne AgeeAnalyst Color Initiation Analyst Ratings

 

Related Articles (ABC)

Around the Web, We're Loving...